Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

KIMMTRAK

TEBENTAFUSP-TEBN

Standard Dose
100MCG/0.5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview KIMMTRAK is listed in Drugs@FDA under application 761228 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TEBENTAFUSP-TEBN Form and strength INJECTABLE;INJECTION - 100MCG/0.5ML Sponsor IMMUNOCORE LTD Submission history Latest submission status date: 2024-06-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview KIMMTRAK is listed in Drugs@FDA under application 761228 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient TEBENTAFUSP-TEBN Form and strength INJECTABLE;INJECTION - 100MCG/0.5ML Sponsor IMMUNOCORE LTD Submission history Latest submission status date: 2024-06-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.